KK

Krishna Kaile

Active Director Director DIN 00987703
DIN 00987703 First appointment Oct 1993 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 1993
Shareholding value •••• Premium profile

About Krishna Kaile

Data last updated:

Krishna Kaile is a Director at Perk Pharmaceuticals Limited (since 1993). The company operates in Pharma. Perk Pharmaceuticals Limited reported revenue of ₹15.71 Cr (FY 2020).

DIN 00987703
Primary Designation Director
Industry Pharma
First Appointment 01 Oct 1993
Oldest Company Age 45 yrs
Largest company Perk Pharmaceuticals Limited · ₹15.71 Cr (FY 2020)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Perk Pharmaceuticals Limited L24231UP1981PLC005400
Director01 Oct 19931981₹15.71 Cr (FY 2020)Active

Board colleagues of Krishna Kaile

NameDINCompanyDesignation
Monica Kaile07329652Perk Pharmaceuticals LimitedDirector
Ritu Kaile07329665Perk Pharmaceuticals LimitedWhole-Time Director

Directorship timeline

Open interactive timeline →
Perk Pharmaceuticals Limited
Premium access

Shareholding and investment profile for Krishna Kaile

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Krishna Kaile

Krishna Kaile currently holds 1 directorship: Perk Pharmaceuticals Limited (Director, since 01 Oct 1993, revenue ₹15.71 Cr (FY 2020)).

Krishna Kaile was first appointed on 01 Oct 1993 as Director at Perk Pharmaceuticals Limited.

The current boards of Krishna Kaile's companies include Monica Kaile (Perk Pharmaceuticals Limited), Ritu Kaile (Perk Pharmaceuticals Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available